Opioid Dependence Treatment Therapies in Pregnancy

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

October 9, 2019

Study Completion Date

October 5, 2020

Conditions
Opioid-Related DisordersPregnancy
Interventions
DRUG

Buprenorphine

This is a pilot study to establish the feasibility and acceptability of a randomized comparative effectiveness clinical trial comparing office-based buprenorphine vs. federally licensed methadone treatment programs for OD pregnant women.

DRUG

Methadone

This is a pilot study to establish the feasibility and acceptability of a randomized comparative effectiveness clinical trial comparing office-based buprenorphine vs. federally licensed methadone treatment programs for OD pregnant women.

Trial Locations (1)

15213

Magee-Womens Hospital of UPMC, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pittsburgh

OTHER

NCT03098407 - Opioid Dependence Treatment Therapies in Pregnancy | Biotech Hunter | Biotech Hunter